Using positron emission tomography and the selective 5-HT1A receptor radioligand [11C]WAY100635, we previously demonstrated a preferential occupancy of 5-HT1A autoreceptors, compared to postsynaptic receptors by pindolol in healthy volunteers. We have speculated that preferential occupancy may be clinically important for the purported actions of pindolol in accelerating the antidepressant effects of selective serotonin re-uptake inhibitors (SSRIs). In this study, we have examined the preferential occupancy by pindolol of 5-HT1A autoreceptors, following three different pindolol regimes (10 mg single dose, 2.5 mg t.i.d., and 5 mg t.i.d., in 15 depressed patients on SSRIs. In addition, seven healthy volunteers were examined following a single ...
The aim of the present clinical positron emission tomography study was to examine if the 5-HTT is a ...
BACKGROUND: Brain serotonin (5-HT) function is abnormal in major depression, but the involvement of ...
AbstractThe β-adrenergic blocker and 5-HT1A receptor antagonist pindolol has been combined with sele...
Augmentation of selective serotonin reuptake inhibitors (SSRIs) therapy by the 5-HT1A receptor agent...
Preclinical studies in rodents suggest that augmentation of serotonin reuptake inhibitors (SSRIs) th...
A novel strategy for improving the treatment of depressive illness is augmentation of antidepressant...
Background: We investigated the combination of selective serotonin reuptake inhibitors (SSRIs) with ...
Serotonin(1A) (5-HT(1A)) receptors have been implicated in the pathophysiology and treatment of anxi...
In microdialysis studies, somatodendritic 5-HT1A receptors in the dorsal raphe nucleus (DRN) were ac...
The beta-adrenergic blocker and 5-HT(1A) receptor antagonist pindolol has been combined with selecti...
Animal studies have demonstrated that the co-administration of pindolol and selective serotonin reup...
International audienceSerotonin (5-hydroxytryptamine, 5-HT) and its various receptors are involved i...
Positron emission tomography (PET) studies with the selective 5-HT(1A) receptor ligand, [(11)C]WAY-1...
OBJECTIVE: A previous positron emission tomography (PET) study reported increased serotonin 5-HT(2A)...
Trabajo presentado en el 30th CINP World Congress, celebrado en Seul, República de Corea, del 3 al 5...
The aim of the present clinical positron emission tomography study was to examine if the 5-HTT is a ...
BACKGROUND: Brain serotonin (5-HT) function is abnormal in major depression, but the involvement of ...
AbstractThe β-adrenergic blocker and 5-HT1A receptor antagonist pindolol has been combined with sele...
Augmentation of selective serotonin reuptake inhibitors (SSRIs) therapy by the 5-HT1A receptor agent...
Preclinical studies in rodents suggest that augmentation of serotonin reuptake inhibitors (SSRIs) th...
A novel strategy for improving the treatment of depressive illness is augmentation of antidepressant...
Background: We investigated the combination of selective serotonin reuptake inhibitors (SSRIs) with ...
Serotonin(1A) (5-HT(1A)) receptors have been implicated in the pathophysiology and treatment of anxi...
In microdialysis studies, somatodendritic 5-HT1A receptors in the dorsal raphe nucleus (DRN) were ac...
The beta-adrenergic blocker and 5-HT(1A) receptor antagonist pindolol has been combined with selecti...
Animal studies have demonstrated that the co-administration of pindolol and selective serotonin reup...
International audienceSerotonin (5-hydroxytryptamine, 5-HT) and its various receptors are involved i...
Positron emission tomography (PET) studies with the selective 5-HT(1A) receptor ligand, [(11)C]WAY-1...
OBJECTIVE: A previous positron emission tomography (PET) study reported increased serotonin 5-HT(2A)...
Trabajo presentado en el 30th CINP World Congress, celebrado en Seul, República de Corea, del 3 al 5...
The aim of the present clinical positron emission tomography study was to examine if the 5-HTT is a ...
BACKGROUND: Brain serotonin (5-HT) function is abnormal in major depression, but the involvement of ...
AbstractThe β-adrenergic blocker and 5-HT1A receptor antagonist pindolol has been combined with sele...